Denmark Interventional Oncology Market Size & Outlook

The interventional oncology market in Denmark is expected to reach a projected revenue of US$ 45.9 million by 2033. A compound annual growth rate of 8.9% is expected of Denmark interventional oncology market from 2026 to 2033.
Revenue, 2025 (US$M)
$23.2
Forecast, 2033 (US$M)
$45.9
CAGR, 2026 - 2033
8.9%
Report Coverage
Denmark

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Denmark interventional oncology market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Denmark interventional oncology market highlights

  • The Denmark interventional oncology market generated a revenue of USD 23.2 million in 2025 and is expected to reach USD 45.9 million by 2033.
  • The Denmark market is expected to grow at a CAGR of 8.9% from 2026 to 2033.
  • In terms of segment, ablation therapies was the largest revenue generating technique in 2025.
  • Ablation Therapies is the most lucrative technique segment registering the fastest growth during the forecast period.


Interventional oncology market data book summary

Market revenue in 2025USD 23.2 million
Market revenue in 2033USD 45.9 million
Growth rate8.9% (CAGR from 2026 to 2033)
Largest segmentAblation therapies
Fastest growing segmentAblation Therapies
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAblation Therapies, Embolization Therapies, Biopsy Techniques, Targeted Therapy Delivery Systems, Image-Guided Procedures
Key market players worldwideMedtronic PLC, Boston Scientific Corp, Johnson & Johnson, Baxter International Inc, Cook Medical, C. R. Bard, Inc., AngioDynamics Inc, Stryker Corp, B. Braun Medical, Terumo Corp, Siemens Healthineers AG ADR, GE HealthCare Technologies Inc Common Stock


Other key industry trends

  • In terms of revenue, Denmark accounted for 0.8% of the global interventional oncology market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany interventional oncology market is projected to lead the regional market in terms of revenue in 2033.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 138.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Interventional Oncology Market Companies

Name Profile # Employees HQ Website
C. R. Bard, Inc. View profile - - -
AngioDynamics Inc View profile 815 14 Plaza Drive, Latham, NY, United States, 12110 https://www.angiodynamics.com
Cook Medical View profile 10001+ Bloomington, Indiana, United States, North America http://www.cookmedical.com
B. Braun Medical View profile 10001+ Bethlehem, Pennsylvania, United States, North America http://www.bbraunusa.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com
Baxter International Inc View profile 60000 One Baxter Parkway, Deerfield, IL, United States, 60015 https://www.baxter.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Denmark interventional oncology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional oncology market will help companies and investors design strategic landscapes.


Ablation therapies was the largest segment with a revenue share of 42.67% in 2025. Horizon Databook has segmented the Denmark interventional oncology market based on ablation therapies, embolization therapies, biopsy techniques, targeted therapy delivery systems, image-guided procedures covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Denmark interventional oncology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Denmark interventional oncology market databook

  • Our clientele includes a mix of interventional oncology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Denmark interventional oncology market , including forecasts for subscribers. This country databook contains high-level insights into Denmark interventional oncology market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Denmark interventional oncology market size, by technique, 2021-2033 (US$M)

Denmark Interventional Oncology Market Outlook Share, 2025 & 2033 (US$M)

Denmark interventional oncology market size, by technique, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online